Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation

Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation

NLRP3 involves in the development of hepatocellular carcinoma (HCC). Eriodictyol has shown its inhibitory effect on HCC cell proliferation. However, the underlying mechanism of eriodictyol in HCC is still unclear. This study aimed to explore the effect of and mechanism of eriodictyol on HCC. In this...

Full description

Bibliographic Details
Main Authors:	Wei Huang, Chenyang Wang, Hui Zhang
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Heliyon
Subjects:	Hepatocellular carcinoma NLRP3 Eriodictyol Metastasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024004328

Similar Items

Eriodictyol and Homoeriodictyol Improve Memory Impairment in Aβ<sub>25–35</sub>-Induced Mice by Inhibiting the NLRP3 Inflammasome
by: Pengli Guo, et al.
Published: (2022-04-01)

Eriodictyol-induced anti-cancer and apoptotic effects in human hepatocellular carcinoma cells are associated with cell cycle arrest and modulation of apoptosis-related proteins
by: Fang Wang, et al.
Published: (2016-03-01)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023-04-01)

Biosynthesis of eriodictyol from tyrosine by Corynebacterium glutamicum
by: Xia Wu, et al.
Published: (2022-05-01)

Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine
by: Frank S. Fan
Published: (2022-10-01)

Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK/Nrf2 signalling pathway
by: Rehab Mustafa Badi, et al.
Published: (2024-03-01)

Eriodictyol corrects functional recovery and myelin loss in SCI rats
by: Li Chenggang, et al.
Published: (2020-12-01)

Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2
by: Defang Li, et al.
Published: (2018-01-01)

Effect of Eriodictyol on Collagen-Induced Arthritis in Rats by Akt/HIF-1α Pathway
by: Lei Z, et al.
Published: (2020-04-01)

Eriodictyol attenuates Furan induced testicular toxicity in Rats: Role of oxidative stress, steroidogenic enzymes and apoptosis
by: Muhammad Umar Ijaz, et al.
Published: (2023-07-01)

Eriodictyol Attenuates MCAO-Induced Brain Injury and Neurological Deficits via Reversing the Autophagy Dysfunction
by: Chuanxiang Wang, et al.
Published: (2021-05-01)

Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2
by: Jozaa Z. AlTamimi, et al.
Published: (2023-11-01)

Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway
by: Wenjun Li, et al.
Published: (2020-02-01)

Eriodictyol can modulate cellular auxin gradients to efficiently promote in vitro cotton fibre development
by: Anam Qadir Khan, et al.
Published: (2019-10-01)

NLRP6-Dependent Pyroptosis-Related lncRNAs Predict the Prognosis of Hepatocellular Carcinoma
by: La Zhang, et al.
Published: (2022-03-01)

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
by: Fang-Ju Cheng, et al.
Published: (2023-06-01)

Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment
by: Zheng Gao, et al.
Published: (2023-05-01)

Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
by: Hui Shan, et al.
Published: (2022-11-01)

Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation
by: Li P, et al.
Published: (2020-04-01)

Eriodictyol as a Potential Candidate Inhibitor of Sortase A Protects Mice From Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia
by: Li Wang, et al.
Published: (2021-02-01)

Optimized De Novo Eriodictyol Biosynthesis in <i>Streptomyces albidoflavus</i> Using an Expansion of the Golden Standard Toolkit for Its Use in Actinomycetes
by: Patricia Magadán-Corpas, et al.
Published: (2023-05-01)

Eriodictyol Attenuates H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Damage in Human Dermal Fibroblasts through Enhanced Capacity of Antioxidant Machinery
by: Visarut Buranasudja, et al.
Published: (2022-06-01)

Eriodictyol attenuates TNBS‐induced ulcerative colitis through repressing TLR4/NF‐kB signaling pathway in rats
by: Li‐Hong Hu, et al.
Published: (2021-09-01)

NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte
by: SM Nashir Udden, et al.
Published: (2019-04-01)

Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma
by: Qian Liu, et al.
Published: (2021-06-01)

Eriodictyol exerts potent anticancer activity against A549 human lung cancer cell line by inducing mitochondrial-mediated apoptosis, G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signalling pathway
by: Yong Zhang, et al.
Published: (2019-05-01)

Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease
by: Yongqing Cai, et al.
Published: (2024-02-01)

Systems Metabolic Engineering of <i>Saccharomyces cerevisiae</i> for the High-Level Production of (2<i>S</i>)-Eriodictyol
by: Siqi Zhang, et al.
Published: (2024-01-01)

Eriodictyol Protects Endothelial Cells against Oxidative Stress-Induced Cell Death through Modulating ERK/Nrf2/ARE-Dependent Heme Oxygenase-1 Expression
by: Seung Eun Lee, et al.
Published: (2015-06-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

Eriodictyol Alleviated LPS/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Cell Apoptosis via PI3K/AKT Signaling Pathway
by: Xiaomei Zheng, et al.
Published: (2023-10-01)

GC-MS/MS Quantification of EGFR Inhibitors, <i>β</i>-Sitosterol, Betulinic Acid, (+) Eriodictyol, (+) Epipinoresinol, and Secoisolariciresinol, in Crude Extract and Ethyl Acetate Fraction of <i>Thonningia sanguinea</i>
by: Sameh S. Elhady, et al.
Published: (2022-06-01)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
by: Wang Jianlong, et al.
Published: (2021-05-01)

A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients
by: Xin Gao, et al.
Published: (2023-01-01)

GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma
by: Sheng Zhang, et al.
Published: (2017-05-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

Eriodictyol decreases very late antigen-4 (VLA-4) expression, cellular adhesion, and migration through an NFκB-dependent pathway in monocytes
by: Tzou-Chi Huang, et al.
Published: (2010-10-01)

Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
by: Choudhury SM, et al.
Published: (2021-03-01)

NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B
by: Hwan Hee Lee, et al.
Published: (2021-08-01)

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
by: Ozer M, et al.
Published: (2023-07-01)